Literature DB >> 21146215

Significantly reduced regulatory T cell population in patients with untreated multiple myeloma.

Ritu Gupta1, Prasanth Ganeshan, Mrinali Hakim, Rakesh Verma, Atul Sharma, Lalit Kumar.   

Abstract

Increases in regulatory T-cells have been demonstrated in hematological malignancies but conflicting results have been reported in multiple myeloma (MM). In this study, we report a decrease in frequency of regulatory T-cells as well as reduced expression of FoxP3 in untreated MM patients which increased significantly after treatment. Regulatory T-cells of MM patients exhibited immunosuppressive activity in an in vitro assay. Reduced regulatory T-cells in untreated MM patients which increased after treatment with thalidomide, suggests the analysis of treated and untreated patients as a single cohort as cause of conflicting results in earlier studies on regulatory T-cells in MM.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146215     DOI: 10.1016/j.leukres.2010.11.010

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  18 in total

1.  Reconstitution of regulatory T cells after autologous transplantation in multiple myeloma.

Authors:  Prasanth Ganeshan; Ritu Gupta; Mrinali Hakim; Lalit Kumar; Archana Bhaskar; Atul Sharma
Journal:  Int J Hematol       Date:  2011-11-03       Impact factor: 2.490

2.  The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.

Authors:  Myriam Foglietta; Barbara Castella; Sara Mariani; Marta Coscia; Laura Godio; Riccardo Ferracini; Marina Ruggeri; Vittorio Muccio; Paola Omedé; Antonio Palumbo; Mario Boccadoro; Massimo Massaia
Journal:  Haematologica       Date:  2014-06-27       Impact factor: 9.941

3.  The immune microenvironment of myeloma.

Authors:  Kimberly Noonan; Ivan Borrello
Journal:  Cancer Microenviron       Date:  2011-08-25

Review 4.  Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma.

Authors:  Xiubao Chang; Yuanxiao Zhu; Changxin Shi; A Keith Stewart
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-12-29       Impact factor: 3.848

5.  Understanding the multiple biological aspects leading to myeloma.

Authors:  Eileen M Boyle; Faith E Davies; Xavier Leleu; Gareth J Morgan
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

Review 6.  Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies.

Authors:  Giovanni D'Arena; Candida Vitale; Marta Coscia; Agostino Festa; Nicola Matteo Dario Di Minno; Vincenzo De Feo; Michele Caraglia; Gioacchino Calapai; Luca Laurenti; Pellegrino Musto; Giovanni Di Minno; Daniela Fenoglio
Journal:  J Immunol Res       Date:  2017-12-21       Impact factor: 4.818

7.  Increased T regulatory cells are associated with adverse clinical features and predict progression in multiple myeloma.

Authors:  Karthick Raja Muthu Raja; Lucie Rihova; Lenka Zahradova; Maria Klincova; Miroslav Penka; Roman Hajek
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

Review 8.  Immunological dysregulation in multiple myeloma microenvironment.

Authors:  Alessandra Romano; Concetta Conticello; Maide Cavalli; Calogero Vetro; Alessia La Fauci; Nunziatina Laura Parrinello; Francesco Di Raimondo
Journal:  Biomed Res Int       Date:  2014-06-11       Impact factor: 3.411

9.  FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells.

Authors:  Walter Moises Tobias Braga; Bruna Raphaeli da Silva; Ana Carolina de Carvalho; Yumi H Maekawa; Adriana Bruscato Bortoluzzo; Edgar Gil Rizzatti; Djordje Atanackovic; Gisele Wally Braga Colleoni
Journal:  Cancer Immunol Immunother       Date:  2014-08-07       Impact factor: 6.968

10.  Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role.

Authors:  Giovanni D'Arena; Giovanni Rossi; Luca Laurenti; Teodora Statuto; Fiorella D'Auria; Luciana Valvano; Vittorio Simeon; Aldo Giudice; Idanna Innocenti; Vincenzo De Feo; Rosanna Filosa; Pellegrino Musto
Journal:  J Immunol Res       Date:  2016-07-14       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.